methyl 5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate
- $485 - $1548
- Product name: methyl 5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate
- CAS: 1264044-28-1
- MF: C11H10ClN3O2
- MW: 251.67
- EINECS:
- MDL Number:MFCD18433820
- Synonyms:methyl 5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate;5-Amino-1-(2-chloro-phenyl)-1H-pyrazole-4-carboxylic acid methyl ester;1H-Pyrazole-4-carboxylic acid, 5-amino-1-(2-chlorophenyl)-, methyl ester
3 prices
Selected condition:
Brand
- Crysdot
Package
- 1g
- 5g
- 10g
- ManufacturerCrysdot
- Product numberCD11303844
- Product descriptionMethyl5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate 97%
- Packaging10g
- Price$1548
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11303844
- Product descriptionMethyl5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate 97%
- Packaging5g
- Price$1107
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11303844
- Product descriptionMethyl5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate 97%
- Packaging1g
- Price$485
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11303844 | Methyl5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate 97% | 10g | $1548 | 2021-12-16 | Buy |
Crysdot | CD11303844 | Methyl5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate 97% | 5g | $1107 | 2021-12-16 | Buy |
Crysdot | CD11303844 | Methyl5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate 97% | 1g | $485 | 2021-12-16 | Buy |
Properties
Boiling point :406.0±35.0 °C(Predicted)
Density :1.42±0.1 g/cm3(Predicted)
pka :0.44±0.13(Predicted)
Density :1.42±0.1 g/cm3(Predicted)
pka :0.44±0.13(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|